2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one has been researched along with Adenocarcinoma of Lung in 8 studies
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one: specific inhibitor of phosphatidylinositol 3-kinase; structure in first source
Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ryu, BJ | 1 |
| Hwang, MK | 1 |
| Park, M | 1 |
| Lee, K | 1 |
| Kim, SH | 1 |
| Liu, XH | 1 |
| Tang, DE | 1 |
| Dai, Y | 1 |
| Gao, XJ | 1 |
| Liu, LX | 1 |
| Sun, Y | 1 |
| Zhang, Z | 1 |
| Xiang, F | 1 |
| Zhang, M | 1 |
| Chen, Q | 1 |
| Tang, L | 1 |
| Zhu, L | 1 |
| Liu, J | 1 |
| Meng, Z | 1 |
| Hu, J | 1 |
| Luo, X | 1 |
| Ni, Z | 1 |
| Wang, X | 1 |
| Akizuki, R | 2 |
| Eguchi, H | 1 |
| Endo, S | 3 |
| Matsunaga, T | 3 |
| Ikari, A | 3 |
| Sun, T | 1 |
| Du, B | 1 |
| Diao, Y | 1 |
| Li, X | 1 |
| Chen, S | 1 |
| Li, Y | 1 |
| Ito, S | 1 |
| Igishi, T | 1 |
| Takata, M | 1 |
| Ueda, Y | 1 |
| Matsumoto, S | 1 |
| Kodani, M | 1 |
| Takeda, K | 1 |
| Izumi, H | 1 |
| Sakamoto, T | 1 |
| Yamaguchi, K | 1 |
| Makino, H | 1 |
| Touge, H | 1 |
| Chikumi, H | 1 |
| Shimizu, E | 1 |
| Sonoki, H | 1 |
| Sato, T | 1 |
| Yamaguchi, M | 1 |
| Yamazaki, Y | 1 |
| Sugatani, J | 1 |
| Hichino, A | 1 |
| Okamoto, M | 1 |
| Taga, S | 1 |
8 other studies available for 2-(4-morpholinyl)-8-phenyl-4h-1-benzopyran-4-one and Adenocarcinoma of Lung
| Article | Year |
|---|---|
Thiourea compound AW00178 sensitizes human H1299 lung carcinoma cells to TRAIL-mediated apoptosis.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Drug Res | 2012 |
PCNA and GSK3β interact with each other to regulate H1299 lung adenocarcinoma cells apoptosis.
Topics: Adenocarcinoma of Lung; Apoptosis; Cell Line, Tumor; Chromones; Gene Knockdown Techniques; Glycogen | 2020 |
Decreasing Arl4c expression by inhibition of AKT signal in human lung adenocarcinoma cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; ADP-Ribosylation Factors; Blotting, Western; Cam | 2020 |
ZO-2 Suppresses Cell Migration Mediated by a Reduction in Matrix Metalloproteinase 2 in Claudin-18-Expressing Lung Adenocarcinoma A549 Cells.
Topics: A549 Cells; Adenocarcinoma of Lung; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chromones; | 2019 |
ATAD2 expression increases [18F]Fluorodeoxyglucose uptake value in lung adenocarcinoma via AKT-GLUT1/HK2 pathway.
Topics: Adenocarcinoma of Lung; ATPases Associated with Diverse Cellular Activities; Cell Movement; Cell Pro | 2019 |
Synergistic cell growth inhibition by the combination of amrubicin and Akt-suppressing agents in K-ras mutation-harboring lung adenocarcinoma cells: implication of EGFR tyrosine kinase inhibitors.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Anthracyclines; Carcinoma, Non-Small-Cell Lung; Cell Line, T | 2014 |
Quercetin Decreases Claudin-2 Expression Mediated by Up-Regulation of microRNA miR-16 in Lung Adenocarcinoma A549 Cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Butadienes; Cell Line, Tumor; Cell Proliferation; Chromones; | 2015 |
Down-regulation of Claudin-2 Expression and Proliferation by Epigenetic Inhibitors in Human Lung Adenocarcinoma A549 Cells.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Azacitidine; Butyric Acid; Cell Proliferation; C | 2017 |